JPH0572919B2 - - Google Patents
Info
- Publication number
- JPH0572919B2 JPH0572919B2 JP19601985A JP19601985A JPH0572919B2 JP H0572919 B2 JPH0572919 B2 JP H0572919B2 JP 19601985 A JP19601985 A JP 19601985A JP 19601985 A JP19601985 A JP 19601985A JP H0572919 B2 JPH0572919 B2 JP H0572919B2
- Authority
- JP
- Japan
- Prior art keywords
- methylcobalamin
- lower aliphatic
- acetone
- water
- highly purified
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- JEWJRMKHSMTXPP-BYFNXCQMSA-M methylcobalamin Chemical compound C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O JEWJRMKHSMTXPP-BYFNXCQMSA-M 0.000 claims description 37
- 235000007672 methylcobalamin Nutrition 0.000 claims description 37
- 239000011585 methylcobalamin Substances 0.000 claims description 37
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 33
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 22
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 17
- 238000004519 manufacturing process Methods 0.000 claims description 13
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 11
- 235000000639 cyanocobalamin Nutrition 0.000 claims description 10
- 239000011666 cyanocobalamin Substances 0.000 claims description 10
- 229960002104 cyanocobalamin Drugs 0.000 claims description 10
- 125000001931 aliphatic group Chemical group 0.000 claims description 9
- 239000011541 reaction mixture Substances 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 239000000741 silica gel Substances 0.000 claims description 5
- 229910002027 silica gel Inorganic materials 0.000 claims description 5
- 239000003463 adsorbent Substances 0.000 claims description 4
- 239000007858 starting material Substances 0.000 claims description 3
- 238000007796 conventional method Methods 0.000 claims description 2
- AAMWFMOHRYFSEU-UHFFFAOYSA-N methanol;propan-2-one;hydrate Chemical compound O.OC.CC(C)=O AAMWFMOHRYFSEU-UHFFFAOYSA-N 0.000 claims description 2
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 claims 6
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 claims 4
- 239000000243 solution Substances 0.000 description 12
- -1 aliphatic ketones Chemical class 0.000 description 10
- YOZNUFWCRFCGIH-BYFNXCQMSA-L hydroxocobalamin Chemical compound O[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O YOZNUFWCRFCGIH-BYFNXCQMSA-L 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 238000001179 sorption measurement Methods 0.000 description 5
- 239000013076 target substance Substances 0.000 description 5
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 235000002639 sodium chloride Nutrition 0.000 description 4
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 235000004867 hydroxocobalamin Nutrition 0.000 description 3
- 239000011704 hydroxocobalamin Substances 0.000 description 3
- 229960001103 hydroxocobalamin Drugs 0.000 description 3
- 239000003456 ion exchange resin Substances 0.000 description 3
- 229920003303 ion-exchange polymer Polymers 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000002156 adsorbate Substances 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 238000007069 methylation reaction Methods 0.000 description 2
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- OVARTBFNCCXQKS-UHFFFAOYSA-N propan-2-one;hydrate Chemical compound O.CC(C)=O OVARTBFNCCXQKS-UHFFFAOYSA-N 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 206010002065 Anaemia megaloblastic Diseases 0.000 description 1
- 241000694440 Colpidium aqueous Species 0.000 description 1
- 208000032131 Diabetic Neuropathies Diseases 0.000 description 1
- 208000000682 Megaloblastic Anemia Diseases 0.000 description 1
- 206010029240 Neuritis Diseases 0.000 description 1
- 206010036105 Polyneuropathy Diseases 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical group [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 231100001016 megaloblastic anemia Toxicity 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 208000027232 peripheral nervous system disease Diseases 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 208000019629 polyneuritis Diseases 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000006276 transfer reaction Methods 0.000 description 1
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP19601985A JPS6256490A (ja) | 1985-09-06 | 1985-09-06 | 高純度メチルコバラミンの製造方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP19601985A JPS6256490A (ja) | 1985-09-06 | 1985-09-06 | 高純度メチルコバラミンの製造方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6256490A JPS6256490A (ja) | 1987-03-12 |
| JPH0572919B2 true JPH0572919B2 (de) | 1993-10-13 |
Family
ID=16350868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP19601985A Granted JPS6256490A (ja) | 1985-09-06 | 1985-09-06 | 高純度メチルコバラミンの製造方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6256490A (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012165934A1 (es) * | 2011-05-30 | 2012-12-06 | Interquim, S.A. De C.V. | Proceso de síntesis de metilcobalamina |
-
1985
- 1985-09-06 JP JP19601985A patent/JPS6256490A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6256490A (ja) | 1987-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4861870A (en) | Process for purifying anthracyclinone glycosides by selective adsorption on resins | |
| JP3134236B2 (ja) | α−グリコシル−Ｌ−アスコルビン酸高含有物の製造方法とその製造のための分離システム | |
| JP3134235B2 (ja) | ２−Ｏ−α−Ｄ−グルコピラノシル−Ｌ−アスコルビン酸高含有物の製造方法 | |
| JPH08143590A (ja) | 高純度メチルコバラミンの製造方法 | |
| JPH0572919B2 (de) | ||
| JPH0572920B2 (de) | ||
| JPS624399B2 (de) | ||
| JP3315158B2 (ja) | グルタチオンの精製法 | |
| US2709669A (en) | Process for separating vitamin b12 active substances from contaminants | |
| US20040082776A1 (en) | Process for recovery of uridine from molasses | |
| EP0679655B1 (de) | Verfahren zur Herstellung von Ascorbinsäurederivaten | |
| JPH07113024B2 (ja) | ピロロキノリンキノンの精製方法 | |
| JPS62242692A (ja) | モラノリン誘導体の製造法 | |
| JPS61115093A (ja) | モラノリン誘導体の製法 | |
| JP3643603B2 (ja) | 精製フラクトオリゴ糖の製造方法 | |
| JPS6337635B2 (de) | ||
| JP3840672B2 (ja) | アスコルビン酸誘導体の製造法 | |
| JPH0631306B2 (ja) | シチジン―５′―ジリン酸コリン１水和物結晶の製造法 | |
| JPH0267256A (ja) | カルニチンおよびカルニチンニトリルの単離精製法 | |
| JPS6117598A (ja) | 高純度非晶性遊離酸型β‐ニコチンアミド‐アデニン‐ジヌクレオチドの製造方法 | |
| JPS648000B2 (de) | ||
| US3461113A (en) | Process for recovering flavin-adenine dinucleotide | |
| JPH01175991A (ja) | ジデオキシイノシンの精製方法 | |
| JPS63130580A (ja) | トリプトフアンの精製法 | |
| JPS61249961A (ja) | トリプトフアンの精製法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Cancellation because of no payment of annual fees |